论文信息 - Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial - 字舞流文

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

F. Martinez | G. Criner | D. Halpin | Dave Singh | D. Lomas | M. Dransfield | R. Wise | D. Lipson | P. Lange | S. Kilbride | N. Martin | Nicola C. Day | C. Jones | P. Lange | Subramanya Kumar | M. Kaisermann | M. Han | D. Lipson | C. E. Jones | David A. Lipson | Neil Martin